Glycolytic Genes Predict Immune Status and Prognosis Non-Small-Cell Lung Cancer Patients with Radiotherapy and Chemotherapy

Figure 8

Validate the constructed risk model in a validation queue. (a) Survival status, risk score distribution, and heat map of candidate gene expression for the validation cohort. (b) Survival curves of patients in high-risk and low-risk groups in the validation cohort. (c) Time-dependent ROC curves of the risk model in the validation cohort. (d) Nomogram of composite risk scores and clinical characteristics in the validation cohort. (e) Nomogram calibration at 3 and 5 years.

(a)

(b)

(c)

(d)

(e)